Table 1.
Socio–demographic, co-morbid illness and drug use history related variables censoring status and survival experience among COVID-19 patients (n=244)
| Variable | Censoring status | Total (%) | Median survival time (days) |
P-value | ||
|
| ||||||
| No of event (%) |
No of censored (%) |
|||||
| Age | ||||||
| < 40 | 47 (88.7) | 6 (11.3) | 53 (21.7) | 6 | 0.004* | |
| 40–49 | 36 (81.8) | 8 (18.2) | 44 (18.0) | 6 | ||
| 50–59 | 33 (80.5) | 8 (19.5) | 41 (16.8) | 8 | ||
| 60–69 | 41 (77.4) | 12 (22.6) | 53 (21.7) | 8 | ||
| ≥ 70 | 34 (64.2) | 19 (35.8) | 53 (21.7) | 22 | ||
| Sex | ||||||
| Female | 64 (81.0) | 15 (19.0) | 79 (32.4) | 9 | 0.091 | |
| Male | 127 (77.0) | 38 (23.0) | 165 (67.6) | 6 | ||
| Preexisting Co-morbid illness | ||||||
| No | 92 (87.6) | 13 (12.4) | 105 (43.0) | 7 | 0.035* | |
| Yes | 99 (71.2) | 40 (28.8) | 139 (56.9) | 8 | ||
| Cardiac | ||||||
| No | 173 (80.5) | 42 (19.5) | 215 (88.1) | 8 | 0.076 | |
| Yes | 18 (62.1) | 11 (37.9) | 29 (11.9) | 20 | ||
| Hypertension | ||||||
| No | 134 (82.7) | 28 (17.3) | 162 (66.4) | 7 | 0.023* | |
| Yes | 57 (69.5) | 25 (30.5) | 82 (33.6) | 9 | ||
| DM | ||||||
| No | 147 (84.5) | 27 (15.5) | 174 (71.3) | 7 | 0.009* | |
| Yes | 44 (62.9) | 26 (37.1) | 70 (28.7) | 8 | ||
| Asthma | ||||||
| No | 180 (78.6) | 49 (21.4) | 229 (93.8) | 8 | 0.312 | |
| Yes | 11 (73.3) | 4 (26.7) | 15 (6.1) | 22 | ||
|
Medication use history within 14 days of admission (ACEIs, ARBs and NSAIDs) |
||||||
| No | 165 (78.2) | 46 (21.8) | 211 (86.5) | 7 | 0.211 | |
| Yes | 26 (78.8) | 7 (21.2) | 33 (13.5) | 20 | ||